Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
gelcotar shampoo 1.25/0.5 %w/w
quinoderm ltd - coal tar solution strong cade oil - shampoo - 1.25/0.5 %w/w
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
gelcotar 1.25/0.5 %w/w shampoo
quinoderm ltd - coal tar solution strong cade oil - shampoo - 1.25/0.5 %w/w
Australia -
engelsk -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
blue planet marine oodinium
aristopet pty ltd - aminacrine hydrochloride; copper (cu) present as copper sulfate - misc. fish tank medication - aminacrine hydrochloride cleanser/sanitiser active 0.24 mg/ml; copper (cu) present as copper sulfate mineral-copper active 5.4 mg/ml - antibiotic & related - fish aquarium | ornamental fish | ornamental fish pond | tropical fish - parasitic diseases
Israel -
engelsk -
Ministry of Health
xalkori 200 mg
pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.
Israel -
engelsk -
Ministry of Health
xalkori 200 mg
pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.
Israel -
engelsk -
Ministry of Health
xalkori 250 mg
pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.
Israel -
engelsk -
Ministry of Health
xalkori 250 mg
pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.
Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
xalkori 250mg capsules
pfizer ltd - crizotinib - capsule - 250mg
Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
xalkori 200mg capsules
pfizer ltd - crizotinib - capsule - 200mg
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
eczederm cream
quinoderm ltd - calamine - cream